Analysis of p53 Tumor Suppressor Gene, H-ras Protooncogene and Proliferating Cell Nuclear Antigen (PCNA) in Squamous Cell Carcinomas of HRA/Skh Mice Following Exposure to 8-Methoxypsoralen (8-MOP) and UVA Radiation (PUVA Therapy)

Toxicologic Pathology

Volumn 33, Issue 2, 2005, Pages 292-299

  Lambertini, Luca ^a   Surin, Kezia ^a   Ton, Thai vu T ^a   Clayton, Natasha ^a   Dunnick, June K ^b   Kim, Yongbaek ^a   Hong, Hue Hua L ^a   Devereux, Theodora R ^c   Sills, Robert C ^a  

^a Laboratory of Experimental Pathology

^b Toxicology Operation Branch

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

mutation; p53; PCNA; PUVA; skin squamous cell carcinoma (SCC); thymine

Indexed keywords

CYCLINE; DNA; METHOXSALEN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EXPOSURE; GENE INACTIVATION; GENE MUTATION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE STRAIN; MUTAGENICITY; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTO ONCOGENE; PUVA; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; TOXICITY TESTING; TUMOR SUPPRESSOR GENE; ULTRAVIOLET A RADIATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; GENES, RAS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; METHOXSALEN; MICE; MICE, NUDE; MUTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS P21(RAS); PUVA THERAPY; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 15244363191     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262390908380     Document Type: Article

References (60)

1. Attardi LD, Jacks T The role of p53 in tumour suppression: lessons from mouse models Cell Mol Life Sci 1999 55 48 63
2. Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF, van der Leun JC, de Gruijl FR Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells Proc Natl Acad Sci USA 1996 93 274-8
3. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion J Investig Dermatol Symp Proc 1996 1 136-42
4. Bruynzeel I, Bergman W, Hartevelt HM, Kenter CC, Van de Velde EA, Schothorst AA, Suurmond D 'High single-dose’ European PUVA regimen also causes an excess of non-melanoma skin cancer Br J Dermatol 1991 124 49 55
5. Cather J, Menter A Novel therapies for psoriasis Am J Clin Dermatol 2002 3 159-73
6. de Gruijl FR, van Kranen HJ, Mullenders LH UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer J Photochem Photobiol B 2001 63 19 27
7. Devereux TR, Anderson MW, Belinsky SA Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse Carcinogenesis 1991 12 299 303
8. Dumaz N, van Kranen HJ, de Vries A, Berg RJ, Wester PW, van Kreijl CF, Sarasin A, Daya-Grosjean L, de Gruijl FR The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice Carcinogenesis 1997 18 897 904
9. Dunnick JK, Forbes PD, Eustis SL, Hardisty JF, Goodman DG Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation Fundam Appl Toxicol 1991 16 92 102
10. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G, McKiernan G, Christiansen I, Oster M, Honigsmann H, Wilford H, Kokoschka E, Rehle T, Perez M, Stingl G, Laroche L Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results N Engl J Med 1987 316 297 303
11. Forbes PD Photocarcinogenesis: an overview J Invest Dermatol 1981 77 139-43
12. Gasparro FP p53 in dermatology Arch Dermatol 1998 134 1029-32
13. Gasparro FP, Felli A, Schmitt IM Psoralen photobiology: the relationship between DNA damage, chromatin structure, transcription, and immunogenic effects Recent Results Cancer Res 1997 143 101-27
14. Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff JM Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks Environ Mol Mutagen 1998 31 105-12
15. Giglia-Mari G, Sarasin A TP53 mutations in human skin cancers Hum Mutat 2003 21 217-28
16. Hong HH, Devereux TR, Melnick RL, Moomaw CR, Boorman GA, Sills RC Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years Toxicol Pathol 2000 28 529-34
17. Hong HL, Ton TV, Devereux TR, Moomaw C, Clayton N, Chan P, Dunnick JK, Sills RC Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years Toxicol Appl Pharmacol 2003 191 227-34
18. Horio T Indications and action mechanisms of phototherapy J Dermatol Sci 2000 23 Suppl 1 S17 21
19. IARC (International Agency for Research on Cancer) Methoxalen: IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans Some pharmaceutical drugs 1980 24 101 24 Lyon, France
20. IARC (International Agency for Research on Cancer) Overall evaluation of carcinogenicity An updating of IARC monographs 1987 1-42 Suppl 7 101 24 Lyon, France
21. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T UV-induced skin damage Toxicology 2003 189 21 39
22. Inga A, Scott G, Monti P, Aprile A, Abbondandolo A, Burns PA, Fronza G Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer Carcinogenesis 1998 19 741-6
23. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity Cancer Res 1993 53 2961-4
24. Klein C, Planker E, Diercks T, Kessler H, Kunkele KP, Lang K, Hansen S, Schwaiger M NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA J Biol Chem 2001 276 49020 7
25. Ko LJ, Prives C p53: puzzle and paradigm Genes Dev 1996 10 1054-72
26. Kreimer-Erlacher H, Seidl H, Back B, Kerl H, Wolf P High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas form PUVA-treated psoriasis patients Photochem Photobiol 2001 74 323-30
27. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin Cancer Res 1992 52 6400-3
28. Lever LR, Farr PM Skin cancers or premalignant lesions occur in half of high-dose PUVA patients Br J Dermatol 1994 131 215-9
29. Lindelof B, Sigurgeirsson B PUVA treatment in Sweden Acta Derm Venereol Suppl (Stockh) 1991 169 3 6
30. Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Johannesson A, Berne B, Christensen OB, Andersson T, Torngren M, Molin L, Nylander-Lundqvist E, Emtestam L PUVA and cancer: a large-scale epidemiological study Lancet 1991 338 91-3
31. Maga G, Hubscher U Proliferating cell nuclear antigen (PCNA): a dancer with many partners J Cell Sci 2003 116 3051-60
32. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Honigsmann H Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients Dermatology 1996 193 185-91
33. Mangues R, Pellicer A ras activation in experimental carcinogenesis Semin Cancer Biol 1992 3 229-39
34. Mann SJ Hair loss and cyst formation in hairless and rhino mutant mice Anat Rec 1971a 170 485-99
35. Mann SJ Varieties of hairless-like mutant mice J Invest Dermatol 1971b 56 170-3
36. McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma Arch Dermatol 2003 139 771-5
37. Monti P, Inga A, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Ghigliotti G, Abbondandolo A, Fronza G p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients Mutagenesis 2000 15 127-32
38. Nataraj AJ, Black HS, Ananthaswamy HN Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers Proc Natl Acad Sci USA 1996 93 7961-5
39. Nataraj AJ, Wolf P, Cerroni L, Ananthaswamy HN p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA) J Invest Dermatol 1997 109 238-43
40. Nishigori C, Wang S, Miyakoshi J, Sato M, Tsukada T, Yagi T, Imamura S, Takebe H Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation Proc Natl Acad Sci USA 1994 91 7189-93
41. Pavletich NP, Chambers KA, Pabo CO The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots Genes Dev 1993 7 2556-64
42. Peritz AE, Gasparro FP Psoriasis, PUVA, and skin cancer—molecular epidemiology: the curious question of T→A transversions J Investig Dermatol Symp Proc 1999 4 11-6
43. Portella G, Liddell J, Crombie R, Haddow S, Clarke M, Stoler AB, Balmain A Molecular mechanisms of invasion and metastasis during mouse skin tumour progression Invasion Metastasis 1994 14 7 16
44. Rao GN, Collins BJ, Giles HD, Heath JE, Foley JF, May RD, Buckley LA Carcinogenicity of 2′,3′-dideoxycytidine in mice Cancer Res 1996 56 4666-72
45. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase Science 1988 239 487-91
46. Santamaria AB, Davis DW, Nghiem DX, McConkey DJ, Ullrich SE, Kapoor M, Lozano G, Ananthaswamy HN p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells Cell Death Differ 2002 9 549-60
47. Sills RC, Boorman GA, Neal JE, Hong HL, Devereux TR McGregor DB, Rice JM, Venitt S Mutations in ras genes in experimental tumours of rodents The Use of Short- and Medium-Term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation 1999 146 Lyon, France IARC Scientific Publications 55 86
48. Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization J Invest Dermatol 2002 119 522-6
49. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL Cutaneous squamous-cell carcinoma in patients treated with PUVA N Engl J Med 1984 310 1156-61
50. Stern RS, Liebman EJ, Vakeva L Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study J Natl Cancer Inst 1998 90 1278-84
51. Stern RS, Lunder EJ Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis Arch Dermatol 1998 134 1582-5
52. Stern RS, Nichols KT, Vakeva LH Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study N Engl J Med 1997 336 1041-5
53. Swinyard EA, Pathak MA Gilman GA, Goodman LS, Rall TW, Murad F Surface-acting drugs The Pharmacologic Basis of Therapeutics 1985 New York Macmillan 120-9
54. Szymanska K, Hainaut P TP53 and mutations in human cancer Acta Biochim Pol 2003 50 231-8
55. Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors Cancer Res 1999 59 3634-40
56. van Kranen HJ, de Gruijl FR, de Vries A, Sontag Y, Wester PW, Senden HC, Rozemuller E, van Kreijl CF Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice Carcinogenesis 1995 16 1141-7
57. Wang XM, McNiff JM, Klump V, Asgari M, Gasparro FP An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA Photochem Photobiol 1997 66 294-9
58. Williams KD, Dunnick J, Horton J, Greenwell A, Eldridge SR, Elwell M, Sills RC P-Nitrobenzoic acid alpha2u nephropathy in 13-week studies is not associated with renal carcinogenesis in 2-year feed studies Toxicol Pathol 2001 29 507-13
59. Wolf P, Kreimer-Erlacher H, Seidl H, Back B, Soyer HP, Kerl H The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients J Invest Dermatol 2004 122 190 200
60. Zhao K, Chai X, Johnston K, Clements A, Marmorstein R Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution J Biol Chem 2001 276 12120 7